The Pharmacy and Drugs Directorate of the Ministry of Health (Minsa) of Panama is carrying out actions in different parts of Panama with the aim of combating the distribution of counterfeit or illicit products.
These actions are taken within the framework of agreement No. 1 from November 29, 2019, by which an internal regulation of the Inter-institutional Executive Committee was approved, which aims to prevent, detect and prosecute these crimes.
The Inter-institutional Executive Committee is made up of the National Customs Authority (ANA), the Public Ministry, the National Police, the National Border Service (SENAFRONT), the National Air-Navy Service (SENAN), the University of Panama (UP) and the Ministry of Health (MINSA).
As explained at the time by Eyra Ruiz, Minister of Health of Panama, the actions are intended to “preserve the health of the country’s inhabitants.”
The new regulation establishes that its purpose is to regulate the functions, duties and procedures of the committee, in addition to establishing strategies for the prevention, detection and prosecution of substandard and allegedly counterfeit or illegal pharmaceutical products.
Brands Protection News